{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:24:51Z","timestamp":1781951091483,"version":"3.54.5"},"reference-count":26,"publisher":"Impact Journals, LLC","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,10,3]]},"DOI":"10.18632\/oncotarget.20620","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T04:53:20Z","timestamp":1504328000000},"page":"79991-80001","source":"Crossref","is-referenced-by-count":22,"title":["Long-term prognosis of Guillain-Barr\u00e9 syndrome not determined by treatment options?"],"prefix":"10.18632","volume":"8","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunkui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Liang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Jilin University, Changchun, China"},{"name":"Department of Life Sciences, The National Natural Science Foundation of China, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182904fcc","article-title":"Mortality in Guillain-Barre syndrome","volume":"80","author":"Jacobs","year":"2013","journal-title":"Neurology"},{"key":"2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0404.2010.01366.x","article-title":"Clinico-electrophysiological findings and prognosis of Guillain-Barr\u00e9 syndrome\u201410 years\u2019 experience","volume":"123","author":"Arpaci","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00415-005-0958-x","article-title":"Long term disability and social status change after Guillain-Barr\u00e9 syndrome","volume":"253","author":"Nobile-Orazio","year":"2006","journal-title":"J Neurol"},{"key":"4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2012.02.026","article-title":"Residual disability 10 years after falling ill in Guillain-Barr\u00e9 syndrome: a prospective follow-up study","volume":"317","author":"Holmqvist","year":"2012","journal-title":"J Neurol Sci"},{"key":"5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1468-1331.2003.00683.x","article-title":"Guillain-Barr\u00e9 syndrome in southern Taiwan: clinical features, prognostic factors and therapeutic outcomes","volume":"10","author":"Lu","year":"2003","journal-title":"Eur J Neurol"},{"key":"6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jns5.12050","article-title":"Guillain-Barr\u00e9 syndrome: subtypes and predictors of outcome from India","volume":"19","author":"Das","year":"2014","journal-title":"J Peripher Nerv Syst"},{"key":"7","first-page":"105","article-title":"Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS)","volume":"225","author":"Garg","year":"2013","journal-title":"J Neurol Sci"},{"key":"8","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/01.WNL.0000055091.96905.D0","article-title":"Guillain-Barr\u00e9 syndrome: a prospective, population-based incidence and outcome survey","volume":"60","author":"Mutani","year":"2003","journal-title":"Neurology"},{"key":"9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2377-13-95","article-title":"Guillain-Barr\u00e9 syndrome: natural history and prognostic factors: a retrospective review of 106 cases","volume":"13","author":"Arpa","year":"2013","journal-title":"BMC Neurol"},{"key":"10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain-Barr\u00e9 syndrome","volume":"6","author":"Jacobs","year":"2007","journal-title":"Lancet Neurol"},{"key":"11","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"Jacobs","year":"2011","journal-title":"Neurology"},{"key":"12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van Doorn","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2174\/187152812800959059","article-title":"Treatment of Guillain-Barr\u00e9 syndrome: a review","volume":"11","author":"Rajabally","year":"2012","journal-title":"Inflamm Allergy Drug Targets"},{"key":"14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3109\/0886022X.2014.890859","article-title":"Management of Guillain-Barr\u00e9 syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India","volume":"36","author":"Siva Kumar","year":"2014","journal-title":"Ren Fail"},{"key":"15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 syndrome Trial Group","volume":"349","author":"No authors listed","year":"1997","journal-title":"Lancet"},{"key":"16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1212\/WNL.52.3.635","article-title":"Fatal Guillain-Barr\u00e9 syndrome","volume":"52","author":"Wijdicks","year":"1999","journal-title":"Neurology"},{"key":"17","doi-asserted-by":"crossref","first-page":"e38157","DOI":"10.1371\/journal.pone.0038157","article-title":"Attenuated EAN in TNF-\u03b1 deficient mice is associated with an altered balance of M1\/M2 macrophage","volume":"7","author":"Zhu","year":"2012","journal-title":"PloS One"},{"key":"18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Jacobs","year":"2014","journal-title":"Brain"},{"key":"19","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review","volume":"130","author":"van Doorn","year":"2007","journal-title":"Brain"},{"key":"20","first-page":"877","article-title":"Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy","volume":"1","author":"Chadwick","year":"1984","journal-title":"Lancet"},{"key":"21","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barr\u00e9 syndrome. The Guillain-Barr\u00e9 syndrome Study Group","volume":"35","author":"No authors listed","year":"1985","journal-title":"Neurology"},{"key":"22","first-page":"750","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Pierce","year":"1978","journal-title":"Lancet"},{"key":"23","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/brain\/awu158","article-title":"Early identification of \u2018acute-onset\u2019 chronic inflammatory demyelinating polyneuropathy","volume":"137","author":"Lin","year":"2014","journal-title":"Brain"},{"key":"24","doi-asserted-by":"crossref","first-page":"s21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Cornblath","year":"1990","journal-title":"Ann Neurol"},{"key":"25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e31820e7b62","article-title":"Recognizing Guillain-Barr\u00e9 syndrome in preschool children","volume":"76","author":"Jacobs","year":"2011","journal-title":"Neurology"},{"key":"26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome","volume":"14","author":"Schmitz","year":"1991","journal-title":"Muscle Nerve"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T13:17:35Z","timestamp":1589203055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":26,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2017,10,3]]}},"alternative-id":["20620","29108381"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20620","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,1]]}}}